Gene expression profiling for the diagnosis of male breast cancer
Our findings highlight the promising performance of the 90-gene expression assay in accurately identifying the tumor origin in MBC. Incorporating this assay into pathological diagnoses has the potential to empower oncologists with precision treatment options, ultimately enhancing the care and outcomes for patients with MBC.
Authors
- Midie Xu
- Yue Pang (ORCID: https://orcid.org/0000-0002-9869-2863)
- Qifeng Wang (ORCID: https://orcid.org/0000-0002-0564-6076)
- Yixin Wo
- Qi Peng (ORCID: https://orcid.org/0000-0002-0763-3500)
- Yifeng Sun (ORCID: https://orcid.org/0000-0003-0957-0547)
- Qinghua Xu
- Shenglin Huang
- Jing Liu (ORCID: https://orcid.org/0009-0007-3796-7046)
Institutions
- Shanghai Medical College of Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1186/s12885-024-13358-4
- Citations
- 3
- Primary Topic
- Male Breast Health Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- National Natural Science Foundation of China